Improved air trapping evaluation in chest computed tomography in children with cystic fibrosis using real-time spirometric monitoring and biofeedback 

Slides:



Advertisements
Similar presentations
Sleep quality and depression–anxiety in mothers of children with two chronic respiratory diseases: Asthma and cystic fibrosis  Ozge Yılmaz, Ayhan Sogut,
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Ian D. Molyneux, Tanya Moon, A. Kevin Webb, Alyn H. Morice 
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
Zhumin Zhang, Suzanne M. Shoff, HuiChuan J. Lai 
Dietary supplementation with multiple micronutrients: No beneficial effects in pediatric cystic fibrosis patients  Johanna H. Oudshoorn, Peter H.C. Klijn,
Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis  H.J.
William G. Flight, Jonathan Shaw, Susan Johnson, A
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Scott D. Sagel, Marci K. Sontag, Meg M
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Successful treatment of cepacia syndrome
Patrick O. Sobande, James D. Acton, Raouf S. Amin, Jeanne Weiland 
HRCT and MRI of the lung in children with cystic fibrosis: Comparison of different scoring systems  Chiara Sileo, Harriet Corvol, Pierre-Yves Boelle,
Sleep quality and depression–anxiety in mothers of children with two chronic respiratory diseases: Asthma and cystic fibrosis  Ozge Yılmaz, Ayhan Sogut,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Regional ventilation in cystic fibrosis measured by electrical impedance tomography  Zhanqi Zhao, Rainald Fischer, Inéz Frerichs, Ullrich Müller-Lisse,
Cirrhosis and other liver disease in cystic fibrosis
John Widger, Sarath Ranganathan, Philip J. Robinson 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.
The ease of breathing test tracks clinical changes in cystic fibrosis
Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation  Shahid I. Sheikh, Frederick R. Long, Karen.
A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF  Christina Schjellerup Dalbøge, Tacjana.
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Claire Keating, Armeen D
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Vitamin A and lung function in CF
Amyloidosis in cystic fibrosis: A case series
Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis  Chiara Abbas, Florian Singer, Sophie Yammine,
A.H. Gifford  Journal of Cystic Fibrosis 
Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure  I.J. Clifton, A.M. Morton, N.S. Ambrose,
Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis  Elizabeth F. Shead, Charles S. Haworth,
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study  Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,
Calculation of the capnographic index based on expiratory molar mass–volume-curves — A suitable tool to screen for cystic fibrosis lung disease  Susanne.
Cytokine gene polymorphisms and severity of CF lung disease
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
A new method of sweat testing: the CF Quantum®sweat test
Lung clearance index during hospital admission in school-age children with cystic fibrosis  Liam Welsh, Christopher Nesci, Haily Tran, Marisol Tomai,
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation  Markus Hofer, Christoph Schmid, Christian Benden, Rudolf Speich,
A simplified, semi-quantitative structural lung disease computed tomography outcome during quiet breathing in infants with cystic fibrosis  Magali Saguintaah,
Mark R. Johnson, Thomas W. Ferkol, Ross W. Shepherd 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Voriconazole therapy in children with cystic fibrosis
V. Terlizzi, A. Tosco, R. Tomaiuolo, A. Sepe, N. Amato, A. Casale, C
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Theresa A. Laguna, Scott D. Sagel, Marci K. Sontag, Frank J. Accurso 
Presentation transcript:

Improved air trapping evaluation in chest computed tomography in children with cystic fibrosis using real-time spirometric monitoring and biofeedback  Thomas Kongstad, Frederik F. Buchvald, Kent Green, Anders Lindblad, Terry E. Robinson, Kim G. Nielsen  Journal of Cystic Fibrosis  Volume 12, Issue 6, Pages 559-566 (December 2013) DOI: 10.1016/j.jcf.2013.05.012 Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Computer biofeedback displaying dynamic volume-time curve during scanning. The red lines mark the 10% and 90% of Slow Vital Capacity volumes to be reached for expiratory and inspiratory sequences. Refer to online supplement for a short video of the bio-feedback animation. Volume-time data are stored for documentation and post-processing. Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 The child is placed in the scanner with the monitor and the pneumotachograph held in place by a support arm. Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Examples of expiratory images with Point Of Interest-markings of unaffected lung tissue without airtrapping, consolidation or large vessels. The mean value of attenuation inside the circle is registered. Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 4 Lung attenuation during inspiratory and expiratory sequences for the Copenhagen A) and Gothenburg B) group. A successful breath hold manoeuvre provides a large change in attenuation between sequences. Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 5 Air trapping scores in the Copenhagen (CPH) and Gothenburg (GTB) centre. A maximum score of 12 is given if air trapping is seen in more than 50% of lung tissue in all 3 expiratory images. The GTB group scores are significantly lower than the CPH group (p<0.0001). Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Fig. 6 Scatter plot showing the correlation between air trapping score and delta attenuation. (R=0.57 p<0.0001) An ineffective breath hold manoeuvre with a small change in lung attenuation is more likely to result in a low air trapping score. Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Supplementary Fig. 1 Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Supplementary Fig. 2 Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Supplementary Fig. 3 Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions

Supplementary Fig. 4 A plot of HU densities on 1mm vs. 3mm slice thicknesses. Journal of Cystic Fibrosis 2013 12, 559-566DOI: (10.1016/j.jcf.2013.05.012) Copyright © 2013 European Cystic Fibrosis Society. Terms and Conditions